Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors

SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma Pharmaceuticals shares fell 3.8% to close at $5.36 on Friday.

GM